hard days for biotechs...I would say that almost all the biotechs i'm following since 3 years are in difficulty to get financing with good terms, and stock prices gave up half of their gains and sometime more! Medmira is not depending of an important clinical trial like some others, but the market is not that good for all related to medical or health. I guess when people realise the value in that undervalued oversold segment, they will rush in it like crazy. Patience!!! Medmira have great products and so many large market to get in or getting stronger like Europe, China, Brazil, Argentina etc! Keep the faith.